Elevated levels of these cytokines are known to promote tumor cell proliferation, angiogenesis, epithelial–mesenchymal transition (EMT), and resistance to apoptosis through activation of NF-κB and STAT3 signaling pathways. This evidence concerns the gene NFKB1 and neoplasm.